Management and outcomes following surgery for gastrointestinal typhoid:an international, prospective, multicentre cohort study by  & Pinkney, Thomas
 
 
Management and outcomes following surgery for
gastrointestinal typhoid
GlobalSurg Collaborative; Pinkney, Thomas
DOI:
10.1007/s00268-018-4624-8
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
GlobalSurg Collaborative & Pinkney, T 2018, 'Management and outcomes following surgery for gastrointestinal
typhoid: an international, prospective, multicentre cohort study ', World journal of surgery, vol. 42, no. 10, pp.
3179-3188. https://doi.org/10.1007/s00268-018-4624-8
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Checked for eligibility: 14/11/2018
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Feb. 2019
ORIGINAL SCIENTIFIC REPORT
Management and Outcomes Following Surgery
for Gastrointestinal Typhoid: An International, Prospective,
Multicentre Cohort Study
GlobalSurg Collaborative
Published online: 3 May 2018
 The Author(s) 2018
Abstract
Background Gastrointestinal perforation is the most serious complication of typhoid fever, with a high disease
burden in low-income countries. Reliable, prospective, contemporary surgical outcome data are scarce in these
settings. This study aimed to investigate surgical outcomes following surgery for intestinal typhoid.
Methods Two multicentre, international prospective cohort studies of consecutive patients undergoing surgery for
gastrointestinal typhoid perforation were conducted. Outcomes were measured at 30 days and included mortality,
surgical site infection, organ space infection and reintervention rate. Multilevel logistic regression models were used
to adjust for clinically plausible explanatory variables. Effect estimates are expressed as odds ratios (ORs) alongside
their corresponding 95% confidence intervals.
Results A total of 88 patients across the GlobalSurg 1 and GlobalSurg 2 studies were included, from 11 countries.
Children comprised 38.6% (34/88) of included patients. Most patients (87/88) had intestinal perforation. The 30-day
mortality rate was 9.1% (8/88), which was higher in children (14.7 vs. 5.6%). Surgical site infection was common, at
67.0% (59/88). Organ site infection was common, with 10.2% of patients affected. An ASA grade of III and above
was a strong predictor of 30-day post-operative mortality, at the univariable level and following adjustment for
explanatory variables (OR 15.82, 95% CI 1.53–163.57, p = 0.021).
Conclusions With high mortality and complication rates, outcomes from surgery for intestinal typhoid remain poor.
Future studies in this area should focus on sustainable interventions which can reduce perioperative morbidity. At a
policy level, improving these outcomes will require both surgical and public health system advances.
Introduction
Typhoid fever is caused primarily by a gram-negative
Salmonella enterica species (Salmonella typhi and Sal-
monella paratyphi). It is commonly transmitted via the
faeco-oral route and is epidemic in areas with poor sani-
tation and limited availability of clean water. One of the
common complications of typhoid fever is gastrointestinal
perforation, which usually requires emergency surgery [1].
These perforations normally occur in the jejunum or ileum,
but there have been several reported cases of colonic and
even gallbladder perforations [2]. Perforation typically
occurs 2–3 weeks after onset of the disease [3]. The
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incidence and outcomes following emergency surgery for
typhoid perforation are poorly described with existing
studies either single centre or retrospective in nature [4].
The disease is rare in countries with good sanitation, but
has continued to be a public health concern in many low-
and middle-income countries (LMICs) [5]. The high mor-
bidity and mortality associated with intestinal typhoid is
exacerbated by lack of access to medical facilities in
remote and rural areas, where delays in presentation can
lead to perforation and severe complications in both chil-
dren and adults [6]. The reported mortality rates in LMICs
can be as high as 62–80% and are highest where presen-
tation to medical services is delayed [7, 8]. In survivors of
intestinal perforation, there is a high level of morbidity,
exerting considerable societal, economic and healthcare
burdens.
Difficulties in the prompt diagnosis of typhoid fever
serve to compound these issues. The gold standard test for
diagnosis of enteric fever is bone marrow culture [9].
Blood cultures to detect S. Typhi and S. Paratyphi are
possible, but have a lower sensitivity than bone marrow
sampling. Unfortunately, in most LMICs where the disease
is endemic, both blood and bone marrow culture are
unavailable, unaffordable or not routinely performed [10].
The GlobalSurg Collaborative has demonstrated the
feasibility of conducting international high-quality data
collection into low-resource centres. This study aimed to
investigate surgical outcomes following surgery for gas-
trointestinal typhoid globally, using an international col-
laborative research network.
Methods
Study settings
Two international, multicentre, prospective, observational
cohort studies were conducted according to pre-specified,
published protocols: GlobalSurg 1 between 1 July 2014 and
31 December 2014, and GlobalSurg 2 between 1 January
2016 and 31 July 2016 (NCT02662231 and
NCT02179112) [11, 12]. The GlobalSurg group collabo-
rative network methodology has been previously described
in detail elsewhere [13]. Local investigators were respon-
sible for ethics or audit registration according to regional or
institutional governance protocols. This study is reported
according to the Strengthening the Reporting of Observa-
tional Studies in Epidemiology (STROBE) guidelines [14].
Patients and procedures
This study is a pre-specified, subgroup analysis of patients
who underwent emergency abdominal surgery for typhoid-
associated gastrointestinal disease with perforation (in-
cluding gallbladder). Any hospital providing acute surgical
care around the world was eligible to enter patient data.
Consecutive patients undergoing emergency (GlobalSurg
1) and emergency or elective (GlobalSurg 2) abdominal
surgery were eligible for inclusion. Only patients with
intra-operatively, pathologically or microbiologically con-
firmed typhoid infection were included within this analysis.
Patients of any age undergoing surgery by any operative
approach (open, laparoscopic and laparoscopic-converted
procedures) were eligible for inclusion. Emergency surgery
was defined as any unplanned (non-elective) operation,
including reoperation after a previous procedure.
Data collection and management
Data were collected on internationally relevant patient,
disease and outcome data. This approach aimed to max-
imise case record completion and data accuracy. Patients
were followed up for 30 days after surgery, with the day of
surgery taken as day zero [11, 12]. Records were uploaded
by local investigators to a secure online website provided
using the Research Electronic Data Capture (REDCap)
system [15]. The lead investigator at each site was
responsible for data accuracy of all cases prior to data
submission. Only data with high levels of completeness
([ 95%) were accepted for analysis.
Patient variables included demographic details (age,
gender, country, diabetes status, smoking status, American
Society of Anesthesiologists (ASA) grade), operative
details (time to operation, operative approach, WHO safer
surgery checklist use, primary procedure performed) and
outcomes (30-day mortality, 30-day reintervention, 30-day
surgical site infection (SSI) and 30-day organ site infection
(OSI) rates). Antibiotic prophylaxis was defined as antibi-
otics which were administered over the perioperative per-
iod, either at induction or during operation prior to opening
a contaminated space, or antibiotic therapy that was com-
menced prior to operation but continued over the periop-
erative period. Due to the lack of microbiological data and
resistance data, it was not feasible to collect data on which
antibiotics were administered. As typhoid commonly
affects children in low- and middle-income countries and
paediatric surgery is commonly performed in separate
units, we chose to compare outcomes across children and
adults to provide further detail in these groups.
Outcome variables
The primary outcome measure was the 30-day post-oper-
ative mortality rate. The secondary outcome measures
included the 30-day reintervention rate, the 30-day organ
space infection rate and the surgical site infection rate,
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defined according to the US Centre for Disease Control and
Prevention (CDC) definitions for SSI [16].
SSI was defined as one of:
• Purulent drainage from the superficial or deep (fascia or
muscle) incision but not from within the organ/space
component of the surgical site;
• At least one of: pain or tenderness; localised swelling;
redness; heat; fever; and the incision is opened
deliberately or spontaneously dehisces;
• Abscess within the wound (clinically or radiologically
detected).
Organ space infections were recorded separately and
defined as intra-abdominal/pelvic infections detected clin-
ically/symptomatically, radiologically or intra-operatively.
Online training modules were completed by collaborators
prior to data collection.
Statistical analysis
Data were summarised using simple percentages for cate-
gorical variables, or means for continuous data which had a
parametric distribution. Summary statistical tests for dif-
ferences across treatment groups were performed, with the
Chi-square test for categorical data and Kruskal–Wallis for
continuous data. Patient groups were cross-tabulated based
on age, with children being classed as under 16 years of
age and adults 16 and over. Univariable models were
constructed to estimate the effect size of clinically plausi-
ble explanatory variables on 30-day outcomes following
surgery for typhoid perforation. Multilevel models were
then used to create models adjusted for clinically plausible
explanatory variables. These multilevel models adjusted
for the individual patient-level risk (level 1) and then for
country effects (level 2). Effect estimates are presented as
odds ratios, alongside the corresponding 95% confidence
intervals. Statistical significance was taken at the level of
p\ 0.05. All analyses were performed in the R statistical
programming program (R Foundation for Statistical Com-
puting, Vienna, AUT) using the Summarizer and Tidyverse
packages.
Results
A total of 88 patients from 11 countries underwent a sur-
gical procedure for gastrointestinal typhoid perforation
during the data collection periods (Fig. 1). Table 1
describes the baseline demographics of included patients.
One patient was included from a high HDI country, two
from middle HDI countries and 85 patients from low HDI
countries. Validation performed in the GlobalSurg 2 data
set demonstrated this approach to have a 93.3% case
ascertainment rate and a high accuracy for categorical
predictors (Cohen’s kappa coefficients[ 0.90), continuous
predictors (Pearson’s correlation coefficient 0.99) and
mortality rate (kappa 0.91).
Patient and intervention characteristics
Of the included study population, 54 were over or equal to
16 years of age and 34 were children. The mean age of
adult patients was 31.5 years (SD 16.1) and was predom-
inantly male (68.5 vs. 22.2%). There were a considerable
number of children who underwent surgery for gastroin-
testinal typhoid perforation (N = 34, 38.6%), with a mean
age of 8.2 years (SD 3.8) with equal numbers of males and
females (44.1 vs. 44.1%). Patients were largely healthy
prior to surgery, with minimal comorbidity, and low ASA
grades (61.4% ASA 1–2). Most patients were non-smokers
(N = 74, 84.1%), and diabetes was rare in this patient
cohort (N = 3 3.4%). The majority (N = 61, 69.3%) of
patients were operated upon after 6 h of admission. All
patients underwent open surgery (laparotomy). Sixteen
(18.2%) patients had bowel resection, whilst 55 (62.5%)
were oversewn or closed primarily without resection. The
WHO surgical safety checklist was used in 52 (59.1%)
patients. Patient characteristics are detailed in Table 1 and
operative characteristics in Table 2.
Outcomes following surgery for intestinal typhoid
Outcomes following surgical intervention for typhoid are
detailed in Tables 3, 4 and 5. Out of 88 patients, eight
(9.1%) died within 30 days of surgery. Children had a
higher mortality rate than adults (14.7 vs. 5.6%), which
was not statistically significant (p = 0.146). At the uni-
variable level, an ASA grade of III or above was signifi-
cantly associated with 30-day post-operative mortality (OR
15.40, 95% CI 2.55–296.00, p = 0.013). Use of the WHO
surgical checklist showed a weak association with lower
30-day mortality compared to whether a checklist was
unavailable or was available but was not used (OR 0.28,
95% CI 0.05–1.36, p = 0.112). In the adjusted multilevel
model, gender could not be included as it prevented model
convergence, due to a low event rate in the respective
gender groups. The association between higher mortality
and ASA grade of III or above persisted in the multilevel
model (OR 15.82, 95% CI 1.53–163.57, p = 0.021).
Following surgery for intestinal typhoid, a high surgical
site infection rate was observed at 67.0% (59/88). There
was also a high organ space infection rate at 10.2% (9/88).
Children had a similar rate of SSI to adults (67.6 vs.
66.7%). An ASA grade of III and above was weakly
associated at the univariable level with surgical site
infection (OR 2.31, 95% CI 0.88–6.61, p = 0.099) and
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female sex (OR 2.98, 95% CI 1.03–10.01, p = 0.056).
When explanatory variables were adjusted for in multi-
variable analysis, there were no associations between
entered explanatory factors and SSI.
Sensitivity analyses
We compared the patient characteristics and the outcomes
of both the GlobalSurg 1 and GlobalSurg 2 studies
(Tables s1 and s2). The event rates of organ space infection
(p = 0.062) and mortality (p = 0.062) were lower in the
GlobalSurg 2 study; however, most other characteristics
remained comparable.
Discussion
This international, multicentre, prospective study has
demonstrated substantial post-operative morbidity follow-
ing surgery for intestinal typhoid. We identified a 30-day
post-operative mortality rate of 9.1%, which was higher in
children, and a high surgical site infection rate of 67.0%.
As typhoid and paratyphoid disproportionately affects
patients in LMICs, this high complication rate following
surgery has substantial repercussions for both patients and
healthcare systems. Concerningly, children appear to have
similarly poor outcomes following surgery for typhoid
perforation. The incidence of typhoid and paratyphoid is
widespread and remains a key public health issues across
LMICs [17]. With growing resistance to first-line antimi-
crobials, surgery for intestinal typhoid is likely to become
more common and the healthcare burden of post-operative
Fig. 1 Study inclusion flowchart
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Table 1 Patient characteristics
Child
(\16 years)
N = 34
Adult
(C16 years)
N = 54
p value
Age (years) Mean (SD) 8.2 (3.8) 31.5 (16.1) \ 0.001
Gender Male 15 (44.1) 37 (68.5) 0.064
Female 15 (44.1) 12 (22.2)
Missing 4 (11.8) 5 (9.3)
ASA I (Normal/healthy) 9 (26.5) 19 (35.2) 0.257
II (Mild systemic disease) 8 (23.5) 18 (33.3)
III (Severe systemic disease) 12 (35.3) 11 (20.4)
IV (Severe systemic disease, constant threat to life) 2 (5.9) 5 (9.3)
V (Not expected to survive without the operation) 1 (2.9) 1 (1.9)
Unknown 2 (5.9) 0 (0.0)
Smoking status Non-smoker 34 (100.0) 40 (74.1) 0.005
Current smoker 0 (0.0) 12 (22.2)
Missing 0 (0.0) 2 (3.7)
Diabetes No 34 (100.0) 51 (94.4) 0.162
Yes 0 (0.0) 3 (5.6)
Antibiotic Prophylaxis No 3 (8.8) 5 (9.3) 0.945
Yes 31 (91.2) 49 (90.7)
Time to operation \6 h 4 (11.8) 22 (40.7) 0.008
[6 h 29 (85.3) 32 (59.3)
Missing 1 (2.9) 0 (0.0)
Bowel resection No 9 (26.5) 13 (24.1) 0.800
Yes 25 (73.5) 41 (75.9)
WHO safer surgery checklist used? No, not available 12 (35.3) 10 (18.5) 0.205
No, but available 5 (14.7) 9 (16.7)
Yes 17 (50.0) 35 (64.8)
Numbers are n (%), unless otherwise indicated. All tests are Chi-square, where a Kruskal–Wallis test has been applied
Table 2 Operative characteristics
Child
(\16 years)
N = 34
Adult
(C16 years)
N = 54
p value
G58 Small bowel: excision of small bowel 5 (14.7) 9 (16.7) 0.272
G67 Small bowel: other open operations on small bowel 0 (0.0) 2 (3.7)
G74 Small bowel: formation of ileostomy 2 (5.9) 10 (18.5)
G784 Small bowel: closure of perforation 25 (73.5) 30 (55.6)
H06 Colon: extended excision of right hemicolon 1 (2.9) 0 (0.0)
H07 Colon: excision of right hemicolon 1 (2.9) 0 (0.0)
H15 Colon: formation of any colonic stoma 0 (0.0) 1 (1.9)
J23 Gallbladder: other open operations on gall bladder 0 (0.0) 1 (1.9)
T28 Abdomen: repair of anterior abdominal wall 0 (0.0) 1 (1.9)
Numbers are n (%), unless otherwise indicated. All tests are Chi-square
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complications will continue to increase [18]. Surgical site
infection, for instance, is not only expensive for healthcare
systems, but associated with serious complications and
longer lengths of stay [19]. In LMICs, prolonged hospital
admissions after surgery for typhoid in patients of working
age can result in the absence from work and societal
commitments, which subsequently impacts on family units
and communities. In children, this can mean time away
from education, which is particularly important in the
context of wider efforts to reduce inequalities in low- and
middle-income countries. Patients and families who have
lost earnings and are required to pay for a prolonged
treatment are at risk of catastrophic impoverishment with
dire long-term consequences [20].
We identified high morbidity rates associated with sur-
gery for typhoid perforation. The reasons for this relate to
the disease itself, as well patient and broader health system
factors. Morbidity rates may reflect international variation
in access to care and to supporting resources to enable
clinical staff to deliver safe surgery. Several other reasons
for this disparity should also be considered. Firstly, lack of
timely access to high-quality medical care may lead to
delays in presentation leading to more advanced disease
requiring surgical care. Secondly, a lack of capacity in
surgery and perioperative care in LMIC settings may
compound risks of delay in presentation, leading to pre-
ventable SSI and death [21]. Lack of appropriate post-op-
erative care, including intensive care facilities, may
contribute to this. Finally, shortages of facilities to perform
routine microbiological testing may result in ineffectual
prophylactic antibiotic usage where antimicrobial resis-
tance exists.
This study employed a multicentre, prospective
approach with standardised outcome assessment and defi-
nitions. This contrasts with much of the current literature
describing outcomes following surgery for intestinal
Table 3 30-day outcomes
Child
(\16 years)
N = 34
Adult
(C16 years)
N = 54
p value
Mortality (30 days) Alive 29 (85.3) 51 (94.4) 0.146
Died 5 (14.7) 3 (5.6)
Reintervention (30 days) No 25 (73.5) 44 (81.5) 0.377
Yes 9 (26.5) 10 (18.5)
Surgical site infection (30 days) No 11 (32.4) 18 (33.3) 0.924
Yes 23 (67.6) 36 (66.7)
Organ space infection (30 days) No 30 (88.2) 48 (88.9) 0.684
Yes 4 (11.8) 5 (9.3)
Missing 0 (0.0) 1 (1.9)
Numbers are n (%), unless otherwise indicated. All tests are Chi-square
Table 4 Model for 30-day mortality
Alive Died OR (univariable) OR (multilevel)
Age (years) Mean (SD) 22 (15.2) 27.6 (32) 1.02 (0.98–1.05, p = 0.378) 1.02 (0.98–1.06, p = 0.290)
Gender Male 47 (65.3) 5 (71.4) – –
Female 25 (34.7) 2 (28.6) 0.75 (0.10–3.77, p = 0.744) –
ASA Under III 55 (68.8) 1 (12.5) – –
III and above 25 (31.2) 7 (87.5) 15.40 (2.55–296.00, p = 0.013) 14.03 (1.55–127.16, p = 0.019)
Time to operation \6 h 25 (31.6) 1 (12.5) – –
[6 h 54 (68.4) 7 (87.5) 3.24 (0.54–62.28, p = 0.283) 2.46 (0.25–24.36, p = 0.442)
WHO safer surgery
checklist used?
No, not available 18 (22.5) 4 (50.0) – –
No, but available 13 (16.2) 1 (12.5) 0.35 (0.02–2.69, p = 0.367) 0.51 (0.04–6.69, p = 0.611)
Yes 49 (61.3) 3 (37.5) 0.28 (0.05–1.36, p = 0.112) 0.36 (0.06–2.12, p = 0.259)
Antibiotic prophylaxis No 8 (10.0) 0 (0.0) – –
Yes 72 (90.0) 8 (100.0) 12,849,865.87 (0.00-NA, p = 0.994) –
Univariable and multilevel models for 30-day mortality. Effect estimates are presented as odds ratios (ORs) alongside the corresponding 95%
confidence interval
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typhoid, which are retrospective in nature. Our study found
markedly higher complication rates compared to the cur-
rent literature, with a surgical site infection between 20 and
40% higher than those previously reported. This is likely
due to the prospective nature of our study and the fact that
validated outcome definitions were employed for the
diagnosis of SSI, and all collaborators were trained in SSI
assessment using online quality assurance modules. Much
of the current evidence is also single centre in nature,
which may reduce its applicability and generalisability
across already diverse LMIC populations. In contrast to
this, our study included patients across 15 countries, cap-
turing practice in a variety of settings. One notable aspect
of this study is the variety of presentations captured,
including a case of gallbladder typhoid requiring chole-
cystectomy. Gallbladder typhoid has previously been
reported and is famously associated with ‘Typhoid Mary’,
an American cook who was found to be an asymptomatic
carrier of typhoid, with bacteria residing in her gallbladder
[22].
Although the collaborative research methodology
employed by this study has been characterised elsewhere in
detail, this study to our knowledge is the first to use such an
approach to study complications of communicable disease.
Our study has shown such data can be collected accurately
and reliably, demonstrated by validation which has found
the data set to be 93.3% accurate. Collaborative working
enables additional resources and research infrastructure to
be made available in settings where resources may be
otherwise limited.
There are several limitations which must be considered
when interpreting the results of this study. The sample size
is small, although 88 patients undergoing surgery are a
large series of intestinal typhoid compared with the
existing literature. Secondly, this is a study which pools
together data from two of the GlobalSurg studies. A period
of 12 months exists between the first and second Glob-
alSurg study, which may lead to a temporal bias from
trends in typhoid incidence. However, in sensitivity anal-
yses comparing both studies limited differences were seen.
We did not collect data surrounding the serotype or other
specific microbiological parameters of typhoid or paraty-
phoid as doing so would have been impractical within the
confines of this study and limited access to diagnostic
resources in included settings. This therefore made it
impractical to collect information on antibiotic therapy,
including type of antibiotics and administration patterns, as
without knowing which bacteria are likely to be present it
would not be possible to estimate whether this was
appropriately targeted. Finally, as this study was purely
observational in nature no causative inference can be
drawn between factors associated with outcomes in this
study.
Surgery for typhoid is accompanied by substantial
morbidity and disproportionately affects a young LMIC
population, as reported in the previous studies [4, 21, 23].
Subsequently, funders and policymakers should identify
means of reducing the overall burden of morbidity and
impact of typhoid upon communities. This should aim to
address three key areas: disease prevention, access to
prompt surgical care and on improving outcomes. Children
are a key group who we have demonstrated to have high
mortality rates, and improving outcomes in this group
should be a priority. Prevention of typhoid through
improved sanitation and vaccination programmes should
continue and efforts increased. Improving access to health
care, particularly surgical care, at an earlier time in the
disease process should be a priority. Future research should
Table 5 Model for 30-day surgical site infection
No Yes OR (univariable) OR (multilevel)
Age (years) Mean (SD) 22.9 (16) 22.3 (17.8) 1.00 (0.97–1.03, p = 0.889) 1.01 (0.97–1.04, p = 0.781)
Gender Male 21 (80.8) 31 (58.5) – –
Female 5 (19.2) 22 (41.5) 2.98 (1.03–10.01, p = 0.056) 2.88 (0.86–9.69, p = 0.087)
ASA Under III 22 (75.9) 34 (57.6) – –
III and above 7 (24.1) 25 (42.4) 2.31 (0.88–6.61, p = 0.099) 2.27 (0.55–9.33, p = 0.256)
Time to operation \6 h 10 (35.7) 16 (27.1) – –
[6 h 18 (64.3) 43 (72.9) 1.49 (0.56–3.90, p = 0.415) 1.46 (0.39–5.48, p = 0.573)
WHO safer surgery
checklist used?
No, not available 9 (31.0) 13 (22.0) – –
No, but available 5 (17.2) 9 (15.3) 1.25 (0.32–5.22, p = 0.755) 0.77 (0.13–4.60, p = 0.774)
Yes 15 (51.7) 37 (62.7) 1.71 (0.59–4.84, p = 0.313) 1.99 (0.31–12.96, p = 0.471)
Antibiotic prophylaxis No 3 (10.3) 5 (8.5) – –
Yes 26 (89.7) 54 (91.5) 1.25 (0.24–5.48, p = 0.775) 0.29 (0.02–3.90, p = 0.350)
Univariable and multilevel models for 30-day mortality. Effect estimates are presented as odds ratios (ORs) alongside the corresponding 95%
confidence interval
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focus on identifying durable vaccinations for typhoid,
addressing inequalities in access to health care and reduc-
ing morbidity rates following surgery for typhoid.
Addressing these issues is particularly important, as resis-
tance to antimicrobial agents is increasing. Preventing
typhoid will reduce antibiotic usage and preserve current
antibiotics for use in severe cases.
Summary and recommendations
1. Surgery for typhoid is accompanied by substantial
morbidity LMIC population as reported in previous
studies. Almost half of the included study population
were children, who similarly high mortality rates and
morbidity rates.
2. Funders and policymakers should identify means of
reducing the overall burden of morbidity and impact of
typhoid upon communities. This should aim to address
three key areas: sanitation, vaccination and access to
prompt surgical care.
3. Focus should shift to prevention of typhoid through
improved sanitation and vaccination programmes. This
approach has had great successes recently, with the
eradication of smallpox and polio. Preventing typhoid
will reduce the number of patients requiring operation
and ensure patients can enjoy fewer absences at work
or school. Improving access to health care, particularly
surgical care, at an earlier time in the disease process
should be a priority. Doing so will enable patients with
typhoid to present to health care earlier point in their
disease process where antibiotic therapy may be more
effective and an operation avoided. Addressing these
issues is particularly important, as resistance to
antimicrobial agents is increasing. Delivery of non-
antibiotic means of preventing typhoid will reduce
antibiotic usage and preserve current antibiotics for use
in severe cases.
4. Future research should focus on identifying means of
reducing morbidity in patients undergoing surgery for
typhoid perforation, in particular reducing the inci-
dence of surgical site infection. Further trials should
attempt to identify the optimal skin preparation agent,
the role of antibiotic prophylaxis and whether the use
of laparoscopy may reduce infection rates after surgery
for typhoid perforation.
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